{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:39:00Z","timestamp":1790789940685,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001349","name":"MOH | National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-000208-01: T.S."],"award-info":[{"award-number":["MOH-000208-01: T.S."]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"MOH | National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-000228-00: S.H.T"],"award-info":[{"award-number":["MOH-000228-00: S.H.T"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001381","name":"National Research Foundation Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001459","name":"Ministry of Education - Singapore","doi-asserted-by":"publisher","award":["MOE-000061-01: T.S."],"award-info":[{"award-number":["MOE-000061-01: T.S."]}],"id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1038\/s41375-023-01993-y","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T18:03:01Z","timestamp":1692295381000},"page":"1969-1981","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["TAL1 hijacks MYCN enhancer that induces MYCN expression and dependence on mevalonate pathway in T-cell acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"37","author":[{"given":"Shi Hao","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1623-615X","authenticated-orcid":false,"given":"Tze King","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yokomori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Zi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen Eng Juh","family":"Yeoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1621-4954","authenticated-orcid":false,"given":"Takaomi","family":"Sanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,17]]},"reference":[{"key":"1993_CR1","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nrc.2016.63","volume":"16","author":"L Belver","year":"2016","unstructured":"Belver L, Ferrando A. The genetics and mechanisms of T cell acute lymphoblastic leukaemia. Nat Rev Cancer. 2016;16:494\u2013507.","journal-title":"Nat Rev Cancer"},{"key":"1993_CR2","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/ng.3909","volume":"49","author":"Y Liu","year":"2017","unstructured":"Liu Y, Easton J, Shao Y, Maciaszek J, Wang Z, Wilkinson MR, et al. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat Genet. 2017;49:1211\u20138.","journal-title":"Nat Genet"},{"key":"1993_CR3","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1182\/blood-2016-10-706465","volume":"129","author":"T Girardi","year":"2017","unstructured":"Girardi T, Vicente C, Cools J, De Keersmaecker K. The genetics and molecular biology of T-ALL. Blood. 2017;129:1113\u201323.","journal-title":"Blood."},{"key":"1993_CR4","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1126\/science.1259037","volume":"346","author":"MR Mansour","year":"2014","unstructured":"Mansour MR, Abraham BJ, Anders L, Berezovskaya A, Gutierrez A, Durbin AD, et al. Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. Science. 2014;346:1373\u20137.","journal-title":"Science"},{"key":"1993_CR5","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1073\/pnas.86.6.2031","volume":"86","author":"CG Begley","year":"1989","unstructured":"Begley CG, Aplan PD, Davey MP, Nakahara K, Tchorz K, Kurtzberg J, et al. Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. Proc Natl Acad Sci USA. 1989;86:2031\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1993_CR6","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/373432a0","volume":"373","author":"RA Shivdasani","year":"1995","unstructured":"Shivdasani RA, Mayer EL, Orkin SH. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1\/SCL. Nature. 1995;373:432\u20134.","journal-title":"Nature."},{"key":"1993_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0092-8674(00)80076-8","volume":"86","author":"C Porcher","year":"1996","unstructured":"Porcher C, Swat W, Rockwell K, Fujiwara Y, Alt FW, Orkin SH. The T cell leukemia oncoprotein SCL\/tal-1 is essential for development of all hematopoietic lineages. Cell. 1996;86:47\u201357.","journal-title":"Cell."},{"key":"1993_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ccr.2012.06.007","volume":"22","author":"T Sanda","year":"2012","unstructured":"Sanda T, Lawton LN, Barrasa MI, Fan ZP, Kohlhammer H, Gutierrez A, et al. Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia. Cancer Cell. 2012;22:209\u201321.","journal-title":"Cancer Cell"},{"key":"1993_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.exphem.2017.06.001","volume":"53","author":"T Sanda","year":"2017","unstructured":"Sanda T, Leong WZ. TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia. Exp Hematol. 2017;53:7\u201315.","journal-title":"Exp Hematol"},{"key":"1993_CR10","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.stem.2010.07.016","volume":"7","author":"NK Wilson","year":"2010","unstructured":"Wilson NK, Foster SD, Wang X, Knezevic K, Schutte J, Kaimakis P, et al. Combinatorial transcriptional control in blood stem\/progenitor cells: genome-wide analysis of ten major transcriptional regulators. Cell Stem Cell. 2010;7:532\u201344.","journal-title":"Cell Stem Cell"},{"key":"1993_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1182\/blood.2018874503","volume":"134","author":"SH Tan","year":"2019","unstructured":"Tan SH, Leong WZ, Ngoc PCT, Tan TK, Bertulfo FC, Lim MC, et al. The enhancer RNA ARIEL activates the oncogenic transcriptional program in T-cell acute lymphoblastic leukemia. Blood. 2019;134:239\u201351.","journal-title":"Blood."},{"key":"1993_CR12","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/leu.2015.195","volume":"30","author":"SH Tan","year":"2016","unstructured":"Tan SH, Yam AW, Lawton LN, Wong RW, Young RA, Look AT, et al. TRIB2 reinforces the oncogenic transcriptional program controlled by the TAL1 complex in T-cell acute lymphoblastic leukemia. Leukemia. 2016;30:959\u201362.","journal-title":"Leukemia."},{"key":"1993_CR13","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1101\/gad.302646.117","volume":"31","author":"WZ Leong","year":"2017","unstructured":"Leong WZ, Tan SH, Ngoc PCT, Amanda S, Yam AWY, Liau WS, et al. ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis. Genes Dev. 2017;31:2343\u201360.","journal-title":"Genes Dev"},{"key":"1993_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1102160","volume":"306","author":"AP Weng","year":"2004","unstructured":"Weng AP, Ferrando AA, Lee W, Morris JPT, Silverman LB, Sanchez-Irizarry C, et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004;306:269\u201371.","journal-title":"Science."},{"key":"1993_CR15","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1101\/gad.1897910","volume":"24","author":"M Tremblay","year":"2010","unstructured":"Tremblay M, Tremblay CS, Herblot S, Aplan PD, H\u00e9bert J, Perreault C, et al. Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes. Genes Dev. 2010;24:1093\u2013105.","journal-title":"Genes Dev"},{"key":"1993_CR16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ccr.2004.05.023","volume":"5","author":"J O\u2019Neil","year":"2004","unstructured":"O\u2019Neil J, Shank J, Cusson N, Murre C, Kelliher M. TAL1\/SCL induces leukemia by inhibiting the transcriptional activity of E47\/HEB. Cancer Cell. 2004;5:587\u201396.","journal-title":"Cancer Cell"},{"key":"1993_CR17","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1182\/blood-2010-08-300343","volume":"118","author":"J Tatarek","year":"2011","unstructured":"Tatarek J, Cullion K, Ashworth T, Gerstein R, Aster JC, Kelliher MA. Notch1 inhibition targets the leukemia-initiating cells in a Tal1\/Lmo2 mouse model of T-ALL. Blood. 2011;118:1579\u201390.","journal-title":"Blood."},{"key":"1993_CR18","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/onc.2010.495","volume":"30","author":"KM Draheim","year":"2011","unstructured":"Draheim KM, Hermance N, Yang Y, Arous E, Calvo J, Kelliher MA. A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice. Oncogene. 2011;30:1252\u201360.","journal-title":"Oncogene."},{"key":"1993_CR19","doi-asserted-by":"publisher","first-page":"18261","DOI":"10.1073\/pnas.0606108103","volume":"103","author":"T Palomero","year":"2006","unstructured":"Palomero T, Lim WK, Odom DT, Sulis ML, Real PJ, Margolin A, et al. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci USA. 2006;103:18261\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1993_CR20","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/nm.3665","volume":"20","author":"D Herranz","year":"2014","unstructured":"Herranz D, Ambesi-Impiombato A, Palomero T, Schnell SA, Belver L, Wendorff AA, et al. A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia. Nat Med. 2014;20:1130\u20137.","journal-title":"Nat Med"},{"key":"1993_CR21","doi-asserted-by":"publisher","first-page":"8022","DOI":"10.1128\/MCB.01091-06","volume":"26","author":"VM Sharma","year":"2006","unstructured":"Sharma VM, Calvo JA, Draheim KM, Cunningham LA, Hermance N, Beverly L, et al. Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc. Mol Cell Biol. 2006;26:8022\u201331.","journal-title":"Mol Cell Biol"},{"key":"1993_CR22","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1101\/gad.1450406","volume":"20","author":"AP Weng","year":"2006","unstructured":"Weng AP, Millholland JM, Yashiro-Ohtani Y, Arcangeli ML, Lau A, Wai C, et al. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia\/lymphoma. Genes Dev. 2006;20:2096\u2013109.","journal-title":"Genes Dev"},{"key":"1993_CR23","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1084\/jem.20122516","volume":"210","author":"MR Mansour","year":"2013","unstructured":"Mansour MR, Sanda T, Lawton LN, Li X, Kreslavsky T, Novina CD, et al. The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia. J Exp Med. 2013;210:1545\u201357.","journal-title":"J Exp Med"},{"key":"1993_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3390\/genes8040113","volume":"8","author":"MV Ruiz-P\u00e9rez","year":"2017","unstructured":"Ruiz-P\u00e9rez MV, Henley AB, Arsenian-Henriksson M. The MYCN protein in health and disease. Genes. 2017;8:113.","journal-title":"Genes"},{"key":"1993_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1158\/2159-8290.CD-17-0273","volume":"8","author":"DS Rickman","year":"2018","unstructured":"Rickman DS, Schulte JH, Eilers M. The expanding world of N-MYC-driven tumors. Cancer Discov. 2018;8:150\u201363.","journal-title":"Cancer Discov"},{"key":"1993_CR26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.18632\/oncotarget.1337","volume":"5","author":"A Astolfi","year":"2014","unstructured":"Astolfi A, Vendemini F, Urbini M, Melchionda F, Masetti R, Franzoni M, et al. MYCN is a novel oncogenic target in pediatric T-cell acute lymphoblastic leukemia. Oncotarget. 2014;5:120\u201330.","journal-title":"Oncotarget."},{"key":"1993_CR27","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1038\/s41375-018-0110-4","volume":"32","author":"PCT Ngoc","year":"2018","unstructured":"Ngoc PCT, Tan SH, Tan TK, Chan MM, Li Z, Yeoh AEJ, et al. Identification of novel lncRNAs regulated by the TAL1 complex in T-cell acute lymphoblastic leukemia. Leukemia. 2018;32:2138\u201351.","journal-title":"Leukemia."},{"key":"1993_CR28","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1101\/gad.14.11.1390","volume":"14","author":"BA Malynn","year":"2000","unstructured":"Malynn BA, de Alboran IM, O\u2019Hagan RC, Bronson R, Davidson L, DePinho RA, et al. N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev. 2000;14:1390\u20139.","journal-title":"Genes Dev"},{"key":"1993_CR29","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1242\/dev.022707","volume":"135","author":"NC Dubois","year":"2008","unstructured":"Dubois NC, Adolphe C, Ehninger A, Wang RA, Robertson EJ, Trumpp A. Placental rescue reveals a sole requirement for c-Myc in embryonic erythroblast survival and hematopoietic stem cell function. Development. 2008;135:2455\u201365.","journal-title":"Development."},{"key":"1993_CR30","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.stem.2008.09.005","volume":"3","author":"E Laurenti","year":"2008","unstructured":"Laurenti E, Varnum-Finney B, Wilson A, Ferrero I, Blanco-Bose WE, Ehninger A, et al. Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity. Cell Stem Cell. 2008;3:611\u201324.","journal-title":"Cell Stem Cell"},{"key":"1993_CR31","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1084\/jem.20112239","volume":"208","author":"P Van Vlierberghe","year":"2011","unstructured":"Van Vlierberghe P, Ambesi-Impiombato A, Perez-Garcia A, Haydu JE, Rigo I, Hadler M, et al. ETV6 mutations in early immature human T cell leukemias. J Exp Med. 2011;208:2571\u20139.","journal-title":"J Exp Med"},{"key":"1993_CR32","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ccell.2018.01.006","volume":"33","author":"CAG Booth","year":"2018","unstructured":"Booth CAG, Barkas N, Neo WH, Boukarabila H, Soilleux EJ, Giotopoulos G, et al. Ezh2 and Runx1 mutations collaborate to initiate lympho-myeloid leukemia in early thymic progenitors. Cancer Cell. 2018;33:274\u201391.e8.","journal-title":"Cancer Cell"},{"key":"1993_CR33","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/nmeth.3630","volume":"12","author":"PI Thakore","year":"2015","unstructured":"Thakore PI, D\u2019Ippolito AM, Song L, Safi A, Shivakumar NK, Kabadi AM, et al. Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements. Nat Methods. 2015;12:1143\u20139.","journal-title":"Nat Methods"},{"key":"1993_CR34","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1158\/2159-8290.CD-19-0789","volume":"10","author":"TE Leon","year":"2020","unstructured":"Leon TE, Rapoz-D\u2019Silva T, Bertoli C, Rahman S, Magnussen M, Philip B, et al. EZH2-deficient T-cell acute lymphoblastic leukemia is sensitized to CHK1 inhibition through enhanced replication stress. Cancer Discov. 2020;10:998\u201317.","journal-title":"Cancer Discov"},{"key":"1993_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nri2507","volume":"9","author":"BL Kee","year":"2009","unstructured":"Kee BL. E and ID proteins branch out. Nat Rev Immunol. 2009;9:175\u201384.","journal-title":"Nat Rev Immunol"},{"key":"1993_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nri2232","volume":"8","author":"EV Rothenberg","year":"2008","unstructured":"Rothenberg EV, Moore JE, Yui MA. Launching the T-cell-lineage developmental programme. Nat Rev Immunol. 2008;8:9\u201321.","journal-title":"Nat Rev Immunol"},{"key":"1993_CR37","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41588-018-0044-9","volume":"50","author":"R Zeid","year":"2018","unstructured":"Zeid R, Lawlor MA, Poon E, Reyes JM, Fulciniti M, Lopez MA, et al. Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma. Nat Genet. 2018;50:515\u201323.","journal-title":"Nat Genet"},{"key":"1993_CR38","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1182\/blood.2022016428","volume":"140","author":"M Vanden Bempt","year":"2022","unstructured":"Vanden Bempt M, Debackere K, Demeyer S, Van Thillo Q, Meeuws N, Fernandez CP, et al. Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T cell lymphoma. Blood. 2022;140:2463\u201376.","journal-title":"Blood."},{"key":"1993_CR39","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.1073\/pnas.1501555112","volume":"112","author":"L Shen","year":"2015","unstructured":"Shen L, O\u2019Shea JM, Kaadige MR, Cunha S, Wilde BR, Cohen AL, et al. Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP. Proc Natl Acad Sci USA. 2015;112:5425\u201330.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1993_CR40","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ccell.2014.11.024","volume":"27","author":"PA Carroll","year":"2015","unstructured":"Carroll PA, Diolaiti D, McFerrin L, Gu H, Djukovic D, Du J, et al. Deregulated Myc requires MondoA\/Mlx for metabolic reprogramming and tumorigenesis. Cancer Cell. 2015;27:271\u201385.","journal-title":"Cancer Cell"},{"key":"1993_CR41","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1038\/ni.3559","volume":"17","author":"B King","year":"2016","unstructured":"King B, Boccalatte F, Moran-Crusio K, Wolf E, Wang J, Kayembe C, et al. The ubiquitin ligase Huwe1 regulates the maintenance and lymphoid commitment of hematopoietic stem cells. Nat Immunol. 2016;17:1312\u201321.","journal-title":"Nat Immunol"},{"key":"1993_CR42","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/nm1636","volume":"13","author":"T Palomero","year":"2007","unstructured":"Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, Ciofani M, et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med. 2007;13:1203\u201310.","journal-title":"Nat Med"},{"key":"1993_CR43","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1158\/0008-5472.CAN-08-4295","volume":"69","author":"SS Rao","year":"2009","unstructured":"Rao SS, O\u2019Neil J, Liberator CD, Hardwick JS, Dai X, Zhang T, et al. Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells. Cancer Res. 2009;69:3060\u20138.","journal-title":"Cancer Res"},{"key":"1993_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.221","volume":"8","author":"SM Lacher","year":"2017","unstructured":"Lacher SM, Bruttger J, Kalt B, Berthelet J, Rajalingam K, Wortge S, et al. HMG-CoA reductase promotes protein prenylation and therefore is indispensible for T-cell survival. Cell Death Dis. 2017;8:e2824.","journal-title":"Cell Death Dis"},{"key":"1993_CR45","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/nrc.2016.76","volume":"16","author":"PJ Mullen","year":"2016","unstructured":"Mullen PJ, Yu R, Longo J, Archer MC, Penn LZ. The interplay between cell signalling and the mevalonate pathway in cancer. Nat Rev Cancer. 2016;16:718\u201331.","journal-title":"Nat Rev Cancer"},{"key":"1993_CR46","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.trecan.2020.11.008","volume":"7","author":"D Juarez","year":"2021","unstructured":"Juarez D, Fruman DA. Targeting the mevalonate pathway in cancer. Trends Cancer. 2021;7:525\u201340.","journal-title":"Trends Cancer"},{"key":"1993_CR47","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1158\/2159-8290.CD-21-0551","volume":"12","author":"M Rashkovan","year":"2022","unstructured":"Rashkovan M, Albero R, Gianni F, Perez-Duran P, Miller HI, Mackey AL, et al. Intracellular cholesterol pools regulate oncogenic signaling and epigenetic circuitries in early T-cell precursor acute lymphoblastic leukemia. Cancer Discov. 2022;12:856\u201371.","journal-title":"Cancer Discov"},{"key":"1993_CR48","doi-asserted-by":"publisher","first-page":"D172","DOI":"10.1093\/nar\/gkt1036","volume":"42","author":"D Chacon","year":"2014","unstructured":"Chacon D, Beck D, Perera D, Wong JW, Pimanda JE. BloodChIP: a database of comparative genome-wide transcription factor binding profiles in human blood cells. Nucleic Acids Res. 2014;42:D172\u20137.","journal-title":"Nucleic Acids Res"}],"updated-by":[{"DOI":"10.1038\/s41375-023-02125-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000}}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-01993-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-01993-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-01993-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T16:05:06Z","timestamp":1706198706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-01993-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,17]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1993"],"URL":"https:\/\/doi.org\/10.1038\/s41375-023-01993-y","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41375-023-02125-2","asserted-by":"object"}]},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,17]]},"assertion":[{"value":"18 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2024","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41375-023-02125-2","URL":"https:\/\/doi.org\/10.1038\/s41375-023-02125-2","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}